How often to see a doctor on tirzepatide or semaglutide
No label we opened sets a visit schedule for tirzepatide (Mounjaro, Zepbound) or semaglutide (Ozempic, Wegovy). The Endocrine Society's 2015 obesity-medicine guideline suggests check-ins at least monthly for 3 months, then at least every 3 months. UK Mounjaro and Wegovy injection labels add a 6-month weight-loss decision point.
Does any label say how often to see a doctor?
The dosing and warning sections of the US and UK labels we opened for tirzepatide and semaglutide set no fixed visit schedule.12345
The US Ozempic label's dosing and warning sections also set no visit schedule.11 The closest wording to a schedule is in the US Wegovy label, which asks for heart rate checks "at regular intervals consistent with usual clinical practice".2
The US Zepbound and Wegovy labels also tell patients to report planned surgery and new symptoms, whenever they happen.12
What check-in schedule do guidelines suggest?
The Endocrine Society's 2015 obesity-medicine guideline suggests checking results and safety at least monthly for 3 months, then at least every 3 months.6
The society rates that suggestion as weak, based on low-quality evidence.6 It dates from 2015 and covers weight-loss medicines in general, so it is not a schedule written for tirzepatide or semaglutide.6
The World Health Organization's December 2025 announcement of its GLP-1 guideline calls for "lifelong, person-centred care".7 The announcement gives no visit schedule, and we could not confirm whether the full guideline does.
Which points in treatment do labels mark out?
Dose steps come at least 4 weeks apart in the labels, and the UK Mounjaro and Wegovy injection labels add a 6-month decision point.1234
The US Zepbound label gives 2.5 mg weekly for 4 weeks, then 5 mg.1 The UK Mounjaro label allows further 2.5 mg rises after at least 4 weeks on the current dose.3
The US Wegovy label raises the injection dose every 4 weeks for 16 weeks. It suggests delaying a step by 4 weeks if a dose is not tolerated.2
The UK Mounjaro label calls for a decision on continuing if you have not lost at least 5% of your initial weight. That point comes 6 months after reaching the highest tolerated dose.3 The UK Wegovy injection label sets the same 5% test after 6 months on treatment.4
For a person who weighed 100 kg at the beginning, 5% is 5 kg.
For teenagers, the UK Wegovy label sets a check after 12 weeks on 2.4 mg or the highest tolerated dose. It says to stop and re-evaluate if BMI has not fallen by at least 5%.4 The dosing sections of the US Zepbound and Wegovy labels set no weight-loss threshold for stopping.12
Which checks and blood tests do the labels ask for?
US and UK labels ask for checks tied to diabetes, side effects and other medicines, and we found no routine blood tests for everyone.1234
If you have diabetes, the US Zepbound and Wegovy labels ask for blood glucose checks before and during treatment.12 The US National Institute of Diabetes and Digestive and Kidney Diseases says experts recommend an A1C test (a 3-month blood sugar average) at least twice a year.8 The US Zepbound label says insulin or sulfonylurea doses may be lowered to reduce the risk of low blood sugar.1
The US Zepbound and UK Mounjaro labels ask for monitoring of diabetic retinopathy (eye damage from diabetes).13 The US labels ask for kidney checks if side effects could cause fluid loss.12
The UK Mounjaro label recommends monitoring people on oral medicines with a narrow therapeutic index, where small dose changes matter.3 The UK Wegovy labels recommend frequent INR clotting tests with warfarin.45 The UK Wegovy tablet label says thyroid checks should be considered in people on levothyroxine.5
UK Mounjaro and Wegovy labels say raised pancreatic enzymes alone do not predict acute pancreatitis.34 The US Zepbound and Wegovy labels call routine calcitonin or thyroid ultrasound monitoring "of uncertain value".12
What do people on GLP-1 medicines report about doctor visits?
From public patient forums: 214 Reddit threads in r/Zepbound, r/WegovyWeightLoss, r/mounjarouk, r/Mounjaro, r/WegovyPillWeightLoss and r/mounjarodeutschland, read October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Not studied Several describe visits about every 2 to 4 months, often with messages between. Several have closer contact during dose increases, then longer gaps once stable. Several others have little or no routine follow-up after the first prescription. We found no study comparing visit schedules on these medicines.
- Not studied Several have dose changes and refills handled by portal, phone or message, without a visit. We found no study of this.
- Matches the label Several have no drug-specific blood tests beyond baseline or usual annual checks, and the US Zepbound and Wegovy labels set no routine panel.12
- Not studied Several others are tested every 2 to 4 months, often during active weight loss or with other conditions. We found no study testing whether routine blood tests change outcomes.
- Matches the label Several threads split on lipase, a pancreas enzyme. Some have it checked, and others say to test only with symptoms. The UK labels say raised enzymes alone do not predict pancreatitis.34
Advice people share
- Not studied Several advise baseline blood tests so later results can be compared, while a few call them unnecessary. We found no study testing either view.
- Label says otherwise Several posts describe partial or extra doses from pens or vials. The UK Mounjaro label gives a once-weekly dose, raised in 2.5 mg steps after at least 4 weeks on the current dose.3
- Label says otherwise A few say contact with a clinician is unnecessary, even with side effects. The US labels ask for kidney checks when side effects could cause fluid loss.12
In your country
No label we opened sets a visit schedule, the UK Mounjaro and Wegovy injection labels add a 6-month decision point, and some countries' own labels could not be checked.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: We could not open Australia's Product Information, so this page relies on the US and UK labels.
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: We did not open Canada's Product Monographs, so this page relies on the US and UK labels.
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: We could not open the EU product information, so this page relies on the US and UK labels.
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open the EU product information, so this page relies on the US and UK labels.
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We did not open an Indian label, so this page relies on the US and UK labels.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a Saudi label, so this page relies on the US and UK labels.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a UAE label, so this page relies on the US and UK labels.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK Mounjaro and Wegovy injection labels add a decision on continuing if weight loss is under 5% at the 6-month points described above.34
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor right away if you have vomiting or diarrhoea that does not go away, as the US Wegovy Medication Guide says. The guide also says to tell them about changes in vision and to call them about gallbladder symptoms such as upper abdominal pain, yellow skin or eyes, fever or clay-coloured stools.2 Contact them right away about signs of low blood sugar too, which the NHS lists as headaches, vision problems, feeling dizzy, weak or confused, a fast heartbeat or sweating.10
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information, Eli Lilly, revised August 2026. uspl.lilly.com
- US Wegovy (semaglutide) prescribing information and Medication Guide, Novo Nordisk, revised June 2026, on DailyMed. dailymed.nlm.nih.gov
- UK Mounjaro KwikPen (tirzepatide) Summary of Product Characteristics, last updated on emc 8 September 2026. medicines.org.uk
- UK Wegovy FlexTouch (semaglutide) injection Summary of Product Characteristics, last updated on emc 22 September 2026. medicines.org.uk
- UK Wegovy 25 mg tablets (semaglutide) Summary of Product Characteristics, last updated on emc 16 June 2026. medicines.org.uk
- Endocrine Society. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100(2):342-362, February 2015. academic.oup.com
- World Health Organization. WHO issues global guideline on the use of GLP-1 medicines in treating obesity, 1 December 2025. who.int
- US National Institute of Diabetes and Digestive and Kidney Diseases. A1C Test. niddk.nih.gov
- MedlinePlus Medical Encyclopedia. Recognizing medical emergencies, citing the American College of Emergency Physicians, reviewed January 2025. medlineplus.gov
- NHS. Tirzepatide. nhs.uk
- US Ozempic (semaglutide) prescribing information, Novo Nordisk, revised May 2026, on DailyMed. dailymed.nlm.nih.gov
Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write